Vaccine Adjuvants Market Report by Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, and Others), Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal, and Others), Diseases (Cancer, Infectious Diseases, and Others), Application (Research, Commercial), and Region 2025-2033

Vaccine Adjuvants Market Report by Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, and Others), Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal, and Others), Diseases (Cancer, Infectious Diseases, and Others), Application (Research, Commercial), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4385

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Vaccine Adjuvants Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Adjuvant Emulsions
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Pathogen Components
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Particulate Adjuvants
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Combination Adjuvants
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intramuscular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Intranasal
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Subcutaneous
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Intradermal
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Diseases
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Infectious Diseases
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Application
    9.1    Research
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Commercial
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Adjuvatis
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Agenus Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Croda International Plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    CSL Limited
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Dynavax Technologies
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    InvivoGen
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Novavax Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    OZ Biosciences
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Phibro Animal Health Corporation
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    SEPPIC
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    SPI Pharma
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Vaccine Adjuvants Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Vaccine Adjuvants Market: Breakup by Product Type (in %), 2024
Figure 5: Global: Vaccine Adjuvants Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Vaccine Adjuvants Market: Breakup by Diseases (in %), 2024
Figure 7: Global: Vaccine Adjuvants Market: Breakup by Application (in %), 2024
Figure 8: Global: Vaccine Adjuvants Market: Breakup by Region (in %), 2024
Figure 9: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Vaccine Adjuvants (Pathogen Components) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Vaccine Adjuvants (Pathogen Components) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Vaccine Adjuvants (Particulate Adjuvants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Vaccine Adjuvants (Particulate Adjuvants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Vaccine Adjuvants (Combination Adjuvants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Vaccine Adjuvants (Combination Adjuvants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Vaccine Adjuvants (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Vaccine Adjuvants (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Vaccine Adjuvants (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Vaccine Adjuvants (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Vaccine Adjuvants (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Vaccine Adjuvants (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Vaccine Adjuvants (Intranasal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Vaccine Adjuvants (Intranasal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Vaccine Adjuvants (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Vaccine Adjuvants (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Vaccine Adjuvants (Intradermal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Vaccine Adjuvants (Intradermal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Vaccine Adjuvants (Other Routes of Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Vaccine Adjuvants (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Vaccine Adjuvants (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Vaccine Adjuvants (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Vaccine Adjuvants (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Vaccine Adjuvants (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Vaccine Adjuvants (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Vaccine Adjuvants (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Vaccine Adjuvants (Research) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Vaccine Adjuvants (Research) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Vaccine Adjuvants (Commercial) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Vaccine Adjuvants (Commercial) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: North America: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: North America: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Canada: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Canada: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Asia-Pacific: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Asia-Pacific: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: China: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: China: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Japan: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Japan: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: India: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: India: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: South Korea: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: South Korea: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Australia: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Australia: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Indonesia: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Indonesia: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Europe: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Europe: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Germany: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Germany: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: France: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: France: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: United Kingdom: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: United Kingdom: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Italy: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Italy: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Spain: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Spain: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Russia: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Russia: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Latin America: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Latin America: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Brazil: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Brazil: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Mexico: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Mexico: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Others: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Middle East and Africa: Vaccine Adjuvants Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Middle East and Africa: Vaccine Adjuvants Market: Breakup by Country (in %), 2024
Figure 89: Middle East and Africa: Vaccine Adjuvants Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Global: Vaccine Adjuvants Industry: SWOT Analysis
Figure 91: Global: Vaccine Adjuvants Industry: Value Chain Analysis
Figure 92: Global: Vaccine Adjuvants Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Vaccine Adjuvants Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Vaccine Adjuvants Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Vaccine Adjuvants Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Vaccine Adjuvants Market Forecast: Breakup by Diseases (in Million USD), 2025-2033
Table 5: Global: Vaccine Adjuvants Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 6: Global: Vaccine Adjuvants Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Vaccine Adjuvants Market: Competitive Structure
Table 8: Global: Vaccine Adjuvants Market: Key Players

Vaccine Adjuvants Market Report by Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, and Others), Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal, and Others), Diseases (Cancer, Infectious Diseases, and Others), Application (Research, Commercial), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials